About
Contact & Profiles
A5099098911
Research Areas
- Liver Disease Diagnosis and Treatment
- Diet and metabolism studies
- Systemic Sclerosis and Related Diseases
- Bariatric Surgery and Outcomes
- Diet, Metabolism, and Disease
Mayo Clinic in Arizona
2025
The recent FDA-approval of resmetirom for treating metabolic dysfunction-associated steatohepatitis (MASH) in patients necessitates patient selection significant fibrosis or higher (≥F2). No existing vibration-controlled transient elastography (VCTE) algorithm targets ≥F2. ALADDIN study addressed this gap by introducing a machine-learning-based web calculator that estimates the likelihood using routine laboratory parameters with and without VCTE. Our included Training set 827 patients,...
10.14309/ajg.0000000000003432
article
EN
cc-by-nc-nd
The American Journal of Gastroenterology
2025-03-27
10.1016/s0168-8278(24)00581-6
article
EN
Journal of Hepatology
2024-06-01
Coming Soon ...